Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala

Overview

Journal Endocrinology

Publisher Oxford University Press

Date 2025 Jan 31

PMID 39888375

Authors

Miguel Duran

Jennifer R Willis

Nilay Dalvi

Zoe Fokakis

Sonja A Virkus

J Andrew Hardaway

Affiliations

Soon will be listed here.

Abstract

Understanding the detailed mechanism of action of glucagon-like peptide 1 receptor (GLP-1R) agonists on distinct topographic and genetically defined brain circuits is critical for improving the efficacy and mitigating adverse side effects of these compounds. In this mini-review, we propose that the central nucleus of the amygdala (CeA) is a critical mediator of GLP-1R agonist-driven hypophagia. Here, we review the extant literature demonstrating CeA activation via GLP-1R agonists across multiple species and through multiple routes of administration. The precise role of GLP-1Rs within the CeA is unclear but the site-specific GLP-1Rs may mediate distinct behavioral and physiological hallmarks of GLP-1R agonists on food intake. Thus, we propose important novel directions and methods to test the role of the CeA in mediating GLP-1R actions.

References

Edwards C, Todd J, Mahmoudi M, Wang Z, Wang R, Ghatei M . Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes. 1999; 48(1):86-93. DOI: 10.2337/diabetes.48.1.86. View

Steinberg E, Gore F, Heifets B, Taylor M, Norville Z, Beier K . Amygdala-Midbrain Connections Modulate Appetitive and Aversive Learning. Neuron. 2020; 106(6):1026-1043.e9. DOI: 10.1016/j.neuron.2020.03.016. View

Yang D, Wang Y, Qi T, Zhang X, Shen L, Ma J . Phosphorylation of pyruvate dehydrogenase inversely associates with neuronal activity. Neuron. 2024; 112(6):959-971.e8. PMC: 11021214. DOI: 10.1016/j.neuron.2023.12.015. View

Arillotta D, Floresta G, Guirguis A, Corkery J, Catalani V, Martinotti G . GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain Sci. 2023; 13(11). PMC: 10669484. DOI: 10.3390/brainsci13111503. View

Huang K, Acosta A, Ghidewon M, McKnight A, Almeida M, Nyema N . Dissociable hindbrain GLP1R circuits for satiety and aversion. Nature. 2024; 632(8025):585-593. DOI: 10.1038/s41586-024-07685-6. View

Xie Y, Zheng J, Li S, Li H, Zhou Y, Zheng W . GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway. Biochem Pharmacol. 2021; 188:114578. DOI: 10.1016/j.bcp.2021.114578. View

Frias J, Davies M, Rosenstock J, Perez Manghi F, Lando L, Bergman B . Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021; 385(6):503-515. DOI: 10.1056/NEJMoa2107519. View

Hsu T, Noble E, Liu C, Cortella A, Konanur V, Suarez A . A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling. Mol Psychiatry. 2017; 23(7):1555-1565. PMC: 5668211. DOI: 10.1038/mp.2017.91. View

Zhang C, Kaye J, Cai Z, Wang Y, Prescott S, Liberles S . Area Postrema Cell Types that Mediate Nausea-Associated Behaviors. Neuron. 2020; 109(3):461-472.e5. PMC: 7864887. DOI: 10.1016/j.neuron.2020.11.010. View

10.

Baird M, Hsu T, Wang R, Juarez B, Zweifel L . κ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety. eNeuro. 2020; 8(1). PMC: 7877472. DOI: 10.1523/ENEURO.0370-20.2020. View

11.

Parker J, McCullough K, Field B, Minnion J, Martin N, Ghatei M . Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int J Obes (Lond). 2013; 37(10):1391-8. DOI: 10.1038/ijo.2012.227. View

12.

Smith N, Hackett T, Galli A, Flynn C . GLP-1: Molecular mechanisms and outcomes of a complex signaling system. Neurochem Int. 2019; 128:94-105. PMC: 7081944. DOI: 10.1016/j.neuint.2019.04.010. View

13.

Roberts G, Woodhams P, Polak J, Crow T . Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience. 1982; 7(1):99-131. DOI: 10.1016/0306-4522(82)90156-7. View

14.

Li C, Navarrete J, Liang-Guallpa J, Lu C, Funderburk S, Chang R . Defined Paraventricular Hypothalamic Populations Exhibit Differential Responses to Food Contingent on Caloric State. Cell Metab. 2018; 29(3):681-694.e5. PMC: 6402975. DOI: 10.1016/j.cmet.2018.10.016. View

15.

Furlan A, Corona A, Boyle S, Sharma R, Rubino R, Habel J . Neurotensin neurons in the extended amygdala control dietary choice and energy homeostasis. Nat Neurosci. 2022; 25(11):1470-1480. PMC: 9682790. DOI: 10.1038/s41593-022-01178-3. View

16.

Baraboi E, Smith P, Ferguson A, Richard D . Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist. Am J Physiol Regul Integr Comp Physiol. 2010; 298(4):R1098-110. DOI: 10.1152/ajpregu.00326.2009. View

17.

Hardaway J, Halladay L, Mazzone C, Pati D, Bloodgood D, Kim M . Central Amygdala Prepronociceptin-Expressing Neurons Mediate Palatable Food Consumption and Reward. Neuron. 2019; 102(5):1037-1052.e7. PMC: 6750705. DOI: 10.1016/j.neuron.2019.03.037. View

18.

Nauck M, Quast D, Wefers J, Meier J . GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Mol Metab. 2020; 46:101102. PMC: 8085572. DOI: 10.1016/j.molmet.2020.101102. View

19.

Gray T, Magnuson D . Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides. 1992; 13(3):451-60. DOI: 10.1016/0196-9781(92)90074-d. View

20.

Liu J, Conde K, Zhang P, Lilascharoen V, Xu Z, Lim B . Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-like Peptide-1 in the Paraventricular Hypothalamus. Neuron. 2017; 96(4):897-909.e5. PMC: 5729931. DOI: 10.1016/j.neuron.2017.09.042. View